← Back to Clinical Trials
Recruiting NCT06123182

NCT06123182 Guided Episodic Future Thinking to Increase Physical Activity Adherence and Promote Healthy Brain Aging

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06123182
Status Recruiting
Phase —
Sponsor University of Kansas Medical Center
Condition Exercise Training
Study Type INTERVENTIONAL
Enrollment 160 participants
Start Date 2024-02-23
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Episodic Future ThinkingEpisodic Recent ThinkingPositive Affective Imagery

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 160 participants in total. It began in 2024-02-23 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this behavioral clinical trial is to learn how to increase physical activity in mid-life adults. Specifically, can guided imagery that includes creating mental pictures increase excitement about working out. Participants will be asked to complete testing at the beginning of the study, following 6-weeks of an in-person exercise program, and 6-weeks after finishing the exercise program. Testing will include an exercise test, MRI, questionnaires, computer tasks, and a blood draw.

Eligibility Criteria

Inclusion Criteria: * speak English * have access to reliable communication (a telephone or cell phone, computer, etc.) * normal or corrected to normal vision and hearing * ambulatory (without the use of assistive devices) * physically underactive * able to give informed consent * able to exercise continuously on the recumbent stepper exercise device for 4 minutes greater than or equal to 25 watts to demonstrate ability to perform exercise on stepper \& no aerobic exercise contraindications or other safety/physical concerns * able to communicate with investigators, follow 2-step command \& correctly answer consent comprehension questions * stable blood pressure and statin medication doses for 30 days as these affect vascular health/hemodynamics * willing and able to safely enter magnetic resonance (MR) scanner and attempt the MR scan * willing and able to attempt a blood draw Exclusion Criteria: * patients with arrhythmias or acute cardiac events will be excluded due to potential complications with the supervised moderate exercise * at risk for hazard due to magnetic fields due to MR safety concerns * have any neurologic or psychiatric disorder except depression, anxiety (including post-traumatic stress disorder) * have history of seizures or head trauma due to MR data quality

Contact & Investigator

Central Contact

Morgan Brucks

✉ mbrucks@kumc.edu

📞 (913) 588-0173

Principal Investigator

Laura Martin

PRINCIPAL INVESTIGATOR

University of Kansas Medical Center

Frequently Asked Questions

Who can join the NCT06123182 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 65 Years, studying Exercise Training. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06123182 currently recruiting?

Yes, NCT06123182 is actively recruiting participants. Contact the research team at mbrucks@kumc.edu for enrollment information.

Where is the NCT06123182 trial being conducted?

This trial is being conducted at Kansas City, United States.

Who is sponsoring the NCT06123182 clinical trial?

NCT06123182 is sponsored by University of Kansas Medical Center. The principal investigator is Laura Martin at University of Kansas Medical Center. The trial plans to enroll 160 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology